Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
aXichem AB (AXIC-A.ST)
SEK2.85
+0.23 (+8.78%)
SE STO Basic Materials Chemicals - Specialty
Address
Södergatan 26 211 34
Malmö, SE
Malmö, SE
CEO
Torsten Helsing
Website
axichem.com
IPO
2011-03-04
ISIN SE0005250719
Description
aXichem AB is a biotechnology firm, established in 2007 and headquartered in Malmö, Sweden, that specializes in creating natural analogue compounds. The company offers aXivite, a capsaicin analogue solution designed for various dietary health applications. Another key product, aXiphen-bio, functions as a biological repellent, providing antifouling protection for marine vessels and installations, and managing pests in agriculture, forestry, and for safeguarding cable infrastructure both within buildings and underground. Additionally, aXiphen-feed is developed to boost the health of poultry, including chickens and hens, as well as swine, such as pigs and piglets.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
SEK2.85
+0.23 (+8.78%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
44.5K
Beta
-0.67
Float Shares
41.87M
Free Float %
70.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.28% | +1.35% | +15.38% | +28.21% | -38.52% | -30.88% | -45.26% | -77.61% | -95.26% | -61.64% | -82.76% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2.85
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
12.28
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+115.2% ★ Q1'26: +13.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+23.1% ★ Q1'26: +54.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-66.0% Q1'26: -117.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-91.8% Q1'26: -68.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-31.1% Q1'26: -19.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+29.2% Q1'26: +7.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-0.39× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 4.0K (-100.0%)
|
—
est: 48.0K (-100.0%)
|
—
est: 5.0K (-100.0%)
|
343.0K
est: 35.00M (-99.0%)
|
1.23M
est: 39.00M (-96.9%)
|
4.36M
est: 3.00M (+45.4%)
|
5.01M
est: 6.00M (-16.6%)
|
1.81M
est: 2.57M (-29.7%)
|
8.57M
est: 9.67M (-11.4%)
|
18.45M
est: 19.55M (-5.6%)
|
38.19M
38.19M – 38.19M
+95.4% YoY
|
83.37M
83.37M – 83.37M
+118.3% YoY
|
127.41M
127.41M – 127.41M
+52.8% YoY
|
173.05M
173.05M – 173.05M
+35.8% YoY
|
226.95M
226.95M – 226.95M
+31.1% YoY
|
| EBITDA |
-7.42M
est: -4.0K (-185,475.0%)
|
-146.0K
est: -48.0K (-204.2%)
|
—
est: -5.0K (+100.0%)
|
-11.07M
est: -35.00M (+68.4%)
|
-12.01M
est: -39.00M (+69.2%)
|
-13.49M
est: -3.00M (-349.7%)
|
-12.44M
est: -6.00M (-107.3%)
|
-15.10M
est: -2.57M (-487.0%)
|
-11.55M
est: -9.00M (-28.3%)
|
-12.04M
est: -18.19M (+33.8%)
|
-35.54M
-35.54M – -35.54M
-95.4% YoY
|
-77.57M
-77.57M – -77.57M
-118.3% YoY
|
-118.55M
-118.55M – -118.55M
-52.8% YoY
|
-161.02M
-161.02M – -161.02M
-35.8% YoY
|
-211.17M
-211.17M – -211.17M
-31.1% YoY
|
| EBIT |
-7.42M
est: -4.0K (-185,475.0%)
|
-6.07M
est: -48.0K (-12,550.0%)
|
-7.18M
est: -5.0K (-143,500.0%)
|
-12.43M
est: -35.00M (+64.5%)
|
-13.51M
est: -39.00M (+65.4%)
|
-15.06M
est: -3.00M (-401.9%)
|
-14.55M
est: -6.00M (-142.4%)
|
-17.32M
est: -2.57M (-573.1%)
|
-15.83M
est: -9.51M (-66.4%)
|
-16.93M
est: -19.23M (+11.9%)
|
-37.57M
-37.57M – -37.57M
-95.4% YoY
|
-82.00M
-82.00M – -82.00M
-118.3% YoY
|
-125.32M
-125.32M – -125.32M
-52.8% YoY
|
-170.21M
-170.21M – -170.21M
-35.8% YoY
|
-223.22M
-223.22M – -223.22M
-31.1% YoY
|
| Net Income |
-7.42M
est: -31.70M (+76.6%)
|
-6.07M
est: -30.71M (+80.2%)
|
-7.38M
est: -20.21M (+63.5%)
|
-12.44M
est: 1.10M (-1,228.8%)
|
-13.52M
est: 13.30M (-201.6%)
|
-15.09M
est: 44.35M (-134.0%)
|
-17.26M
est: 115.30M (-115.0%)
|
-20.81M
est: -40.25M (+48.3%)
|
-17.81M
est: -44.16M (+59.7%)
|
-17.63M
est: -40.20M (+56.1%)
|
-22.03M
-22.03M – -22.03M
+45.2% YoY
|
8.93M
8.93M – 8.93M
+140.5% YoY
|
22.03M
22.03M – 22.03M
+146.7% YoY
|
35.13M
35.13M – 35.13M
+59.5% YoY
|
50.02M
50.02M – 50.02M
+42.4% YoY
|
| SGA |
5.06M
est: 7.5K (+67,174.2%)
|
4.07M
est: 90.2K (+4,408.1%)
|
5.28M
est: 9.4K (+56,034.9%)
|
6.25M
est: 65.78M (-90.5%)
|
6.04M
est: 73.30M (-91.8%)
|
6.67M
est: 5.64M (+18.4%)
|
14.76M
est: 11.28M (+30.9%)
|
—
est: 4.84M (-100.0%)
|
—
est: 8.66M (-100.0%)
|
—
est: 17.51M (-100.0%)
|
34.21M
34.21M – 34.21M
+95.4% YoY
|
74.66M
74.66M – 74.66M
+118.3% YoY
|
114.11M
114.11M – 114.11M
+52.8% YoY
|
154.99M
154.99M – 154.99M
+35.8% YoY
|
203.26M
203.26M – 203.26M
+31.1% YoY
|
| EPS |
-0.94
est: -0.69 (-36.7%)
|
-0.65
est: -0.67 (+2.5%)
|
-0.50
est: -0.44 (-14.0%)
|
-0.77
est: 0.02 (-3,319.6%)
|
-0.82
est: 0.29 (-384.1%)
|
-0.89
est: 0.96 (-192.5%)
|
-1.00
est: 2.50 (-140.0%)
|
-1.03
est: -0.87 (-18.0%)
|
-0.39
est: -0.74 (+47.4%)
|
-0.30
est: -0.68 (+55.6%)
|
-0.37
-0.37 – -0.37
+45.2% YoY
|
0.15
0.15 – 0.15
+140.5% YoY
|
0.37
0.37 – 0.37
+146.7% YoY
|
0.59
0.59 – 0.59
+59.5% YoY
|
0.84
0.84 – 0.84
+42.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.87M
OE per share TTM
-0.20
Owner's Yield
-11.37%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-2.42M
Shares Outstanding
59.55M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Torsten Helsing | Chief Executive Officer & Director | 2M | male |
| Lucas Altepost | Vice President and Chief Sales & Marketing officer | 2M | male |
| Erik Lager | Chief Operations Officer | 1M | male |
| Gunilla Savring | Chief Investor Relations Officer | 663.3K | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AXIC-A.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
